Zepbound vs Wegovy vs Ozempic: What’s the Real Difference Between These 3?
Zepbound vs Wegovy vs Ozempic: What’s the Real Difference Between These 3?

Introduction
If you’re considering a GLP-1 medication for weight loss, you’ve likely heard of Zepbound, Wegovy, and Ozempic. But with so many names floating around—and some containing the same active ingredient—it’s easy to get confused.
In this blog, we’ll break down the differences and similarities between Zepbound vs Wegovy vs Ozempic to help you understand which one is right for your health goals.
Quick Snapshot
Feature |
Zepbound |
Wegovy |
Ozempic |
Active Ingredient |
Tirzepatide |
Semaglutide (2.4 mg) |
Semaglutide (0.5–2 mg) |
Hormones Targeted |
GLP-1 + GIP |
GLP-1 only |
GLP-1 only |
FDA Approval For |
Obesity (2023) |
Obesity (2021) |
Type 2 Diabetes (2017) |
Primary Use |
Weight loss |
Weight loss |
Blood sugar control |
Weight Loss (Avg.) |
15–22.5% |
10–16% |
10–15% (off-label for weight) |
Format |
Weekly injection |
Weekly injection |
Weekly injection |
All three are once-weekly injectables, but only Zepbound and Wegovy are FDA-approved specifically for weight loss.
Zepbound: Dual-Hormone Weight Loss Power
- Activates both GLP-1 and GIP, mimicking natural gut hormones
- Leads to the greatest weight loss in clinical studies
- Helps regulate blood sugar, suppress appetite, and increase fat burning
- Approved for chronic weight management
Source: SURMOUNT-1 Trial
Zepbound is currently the most effective GLP-1-based medication on the market.
Wegovy: High-Dose Semaglutide for Weight Loss
- Contains semaglutide 2.4 mg, a higher dose than Ozempic
- FDA-approved for obesity and overweight
- Suppresses appetite, slows digestion, and improves insulin sensitivity
- Designed specifically for weight loss in non-diabetics
Source: STEP-1 Trial
If you’ve used Ozempic for diabetes or off-label weight loss, Wegovy is the next logical step.
Ozempic: Diabetes Medication Used Off-Label for Weight Loss
- Originally created to treat Type 2 diabetes
- Contains lower doses of semaglutide than Wegovy
- Suppresses appetite but is not approved for weight loss
- Often prescribed off-label for people who can’t access Wegovy
Source: Ozempic Prescribing Info (FDA)
Many people start on Ozempic while waiting for insurance approval for Wegovy or Zepbound.
Weight Loss Results Compared
Medication |
Avg. Body Weight Loss |
Study Duration |
Zepbound |
Up to 22.5% |
72 weeks |
Wegovy |
14.9% |
68 weeks |
Ozempic |
10–15% (off-label) |
68+ weeks |
Zepbound leads the pack, especially for non-diabetics seeking major fat loss.
Insurance, Cost, and Access
Factor |
Zepbound |
Wegovy |
Ozempic |
FDA Weight Loss Approved |
|
|
|
Insurance Coverage |
|
|
|
Retail Cost |
~$1,060/month |
~$1,350/month |
~$900–$1,200/month |
Savings Program |
Wegovy and Zepbound are usually covered with prior authorization. Ozempic is often rejected for non-diabetic use.
Final Thoughts
Each medication has its strengths—but here’s how to choose:
Choose Zepbound if you want maximum weight loss, especially if you’re dealing with insulin resistance or PCOS.
Choose Wegovy if you want FDA-approved semaglutide for weight loss, and prefer a single-hormone option.
Choose Ozempic if you need blood sugar control or want a stepping stone to Wegovy while waiting for approval.
Visit our GLP-1 Med Comparison Hub to download our side-by-side chart, check current pricing, and connect with a telehealth provider.